Reply to “COVID-19 can present with a rash and be mistaken for dengue”: Petechial rash in a patient with COVID-19 infection
2020; Elsevier BV; Volume: 83; Issue: 2 Linguagem: Inglês
10.1016/j.jaad.2020.04.016
ISSN1097-6787
AutoresJuan Jimenez‐Cauhe, Daniel Ortega‐Quijano, Marta Barrios, Óscar M. Moreno‐Arrones, Diego Fernández‐Nieto,
Tópico(s)Eosinophilic Disorders and Syndromes
ResumoTo the Editor: We read with interest the article by Joob et al1Joob B. Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue.J Am Acad Dermatol. 2020; 82: e177Abstract Full Text Full Text PDF PubMed Scopus (336) Google Scholar hypothesizing that COVID-19 infection might present with a skin rash and petechiae. During the COVID-19 outbreak in China, clinical studies did obviously not focus on the skin manifestations of COVID-19. However, it is likely they exist and are probably under-recognized because of the current lack of dermatology consultations in these patients. Recently, Recalcati et al2Recalcati S. Cutaneous manifestations in COVID-19: a first perspective.J Eur Acad Dermatol Venereol. 2020; 34: e212-e213Crossref PubMed Scopus (922) Google Scholar reported the cutaneous manifestations of COVID-19 infection in Italy and described 3 main patterns: erythematous rash, urticaria, and chickenpox-like lesions. However, these 2 published articles did not include clinical images due to safety concerns with transmission of the virus or to a low suspicion of association with it. These weeks we are living the same dramatic situation in Spain, especially in Madrid, and we are beginning to observe some skin manifestations in patients with COVID-19 infection (Fig 1). Whether skin lesions in patients with COVID-19 infection are specific to COVID is still unclear. Viral rashes and drug reactions are clinically and histologically similar and often hard to distinguish. The patient pictured above received hydroxychloroquine and lopinavir/ritonavir, but drug reactions are rare with these agents. In addition, it is not unlikely that COVID-19 may have cutaneous manifestations, because it occurs with other common viral infections. A thorough history of the patient must be obtained to assess the etiology, especially possible eliciting drugs, and time relationship to both drug intake and onset of the COVID-19 symptoms. Dermatologists have a unique opportunity to study COVID-19 cutaneous manifestations during this pandemic, and illustrative images are the first step for other colleagues to start looking for them. A golden principle of medicine becomes now more important: "The more you see, the more you know; and the more you know is the more you see." COVID-19 can present with a rash and be mistaken for dengueJournal of the American Academy of DermatologyVol. 82Issue 5PreviewTo the Editor: We found the report "What are we doing in the dermatology outpatient department amidst the raging of 2019-CoV?" to be very interesting.1 Chen et al pointed out the need for a dermatology department to recognize and deal with this infection. Full-Text PDF Reply to: "Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection"Journal of the American Academy of DermatologyVol. 83Issue 2PreviewTo the Editor: We appreciate the additional information from Jimenez-Cauhe et al1 on our report on a skin rash in a patient with COVID-19.2 Jimenez-Cauhe et al1 showed a clinical picture of a skin rash at the axilla of a patient. As a new emerging virus infection, the dermatologic presentation is an interesting clinical feature. Full-Text PDF
Referência(s)